Temper Buzz About the First Oral GLP-1 Agonist, Rybelsus

November 2019

Rybelsus (reh-BEL-sus, semaglutide) will be the first ORAL GLP-1 agonist for type 2 diabetes...it's a tablet version of injectable Ozempic.

Glucagon-like peptide-1 (GLP-1) is inactivated in the stomach.

That's why other GLP-1 agonists...Bydureon (exenatide), Trulicity (dulaglutide), Victoza (liraglutide), etc...are injected.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Med Safety Put Concerns About Ranitidine and Drug Safety in Perspective
Diabetes Temper Buzz About the First Oral GLP-1 Agonist, Rybelsus
Medicare Avoid Pitfalls With Medicare Rxs for DME
Pain Management Clarify How to Treat Acute Pain in Patients on Buprenorphine/Naloxone
Heart Failure Don't Jump to an SGLT2 Inhibitor for Heart Failure
Alcohol Be Ready to Answer the Question, "Is It Okay to Drink Alcohol With This Med?"
HIV & AIDS Know How Descovy and Truvada Stack Up for HIV Pre-Exposure Prophylaxis (PrEP)
Hypoglycemia Compare Baqsimi or Gvoke With IM Glucagon for Severe Hypoglycemia
Breast Cancer Weigh Pros and Cons of Meds for Primary Prevention of Breast Cancer
Dermatology Set Realistic Expectations for Patients Asking About Scar Treatments